Several prognostic factors for patients with metastatic pancreatic cancer (MPC) have been previously identified: pancreatic cancer location [6], albumin level (ALB), carbohydrate antigen 19-9 level (CA19-9), alkaline phosphatase level (ALP), lactate dehydrogenase level, white blood cell count, aspartate aminotransferase level, blood urea nitrogen level [7], long-standing diabetes [8], Eastern Cooperative Oncology Group (ECOG) performance status, C-reactive protein level [9], the status of unresectable disease, carcinoembryonic antigen level and neutrophil–lymphocyte ratio [10]. This evidence concerns the gene ALB and pancreatic neoplasm.